181 related articles for article (PubMed ID: 27748833)
21. Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells.
Allen KT; Chin-Sinex H; DeLuca T; Pomerening JR; Sherer J; Watkins JB; Foley J; Jesseph JM; Mendonca MS
Free Radic Biol Med; 2015 Dec; 89():263-73. PubMed ID: 26393423
[TBL] [Abstract][Full Text] [Related]
22. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
[TBL] [Abstract][Full Text] [Related]
23. Dichloroacetate affects proliferation but not survival of human colorectal cancer cells.
Delaney LM; Ho N; Morrison J; Farias NR; Mosser DD; Coomber BL
Apoptosis; 2015 Jan; 20(1):63-74. PubMed ID: 25344893
[TBL] [Abstract][Full Text] [Related]
24. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
25. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
Packeiser EM; Hewicker-Trautwein M; Thiemeyer H; Mohr A; Junginger J; Schille JT; Murua Escobar H; Nolte I
PLoS One; 2020; 15(3):e0230272. PubMed ID: 32168360
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
[TBL] [Abstract][Full Text] [Related]
27. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
28. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.
Nayak MK; Dhanesha N; Doddapattar P; Rodriguez O; Sonkar VK; Dayal S; Chauhan AK
Blood Adv; 2018 Aug; 2(15):2029-2038. PubMed ID: 30108111
[TBL] [Abstract][Full Text] [Related]
29. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas.
Cook KM; Shen H; McKelvey KJ; Gee HE; Hau E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298883
[TBL] [Abstract][Full Text] [Related]
30. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
[TBL] [Abstract][Full Text] [Related]
31. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW
Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900
[TBL] [Abstract][Full Text] [Related]
32. NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells.
Kailavasan M; Rehman I; Reynolds S; Bucur A; Tozer G; Paley M
NMR Biomed; 2014 May; 27(5):610-6. PubMed ID: 24639007
[TBL] [Abstract][Full Text] [Related]
33. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
[TBL] [Abstract][Full Text] [Related]
34. Dichloroacetate and cancer: new home for an orphan drug?
Kankotia S; Stacpoole PW
Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892
[TBL] [Abstract][Full Text] [Related]
35. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
[TBL] [Abstract][Full Text] [Related]
37. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity.
Ohashi T; Akazawa T; Aoki M; Kuze B; Mizuta K; Ito Y; Inoue N
Int J Cancer; 2013 Sep; 133(5):1107-18. PubMed ID: 23420584
[TBL] [Abstract][Full Text] [Related]
38. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
39. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
[TBL] [Abstract][Full Text] [Related]
40. Dichloroacetate stimulates changes in the mitochondrial network morphology via partial mitophagy in human SH-SY5Y neuroblastoma cells.
Pajuelo-Reguera D; Alán L; Olejár T; Ježek P
Int J Oncol; 2015; 46(6):2409-18. PubMed ID: 25846762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]